Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Noble International
|
| gptkbp:audience |
Promotes employee engagement initiatives
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:benefits |
Offers competitive employee benefits
|
| gptkbp:business_model |
Plans for business continuity
|
| gptkbp:category |
Inhalation, injection, and topical delivery
|
| gptkbp:ceo |
Stefan J. H. Scherer
|
| gptkbp:clinical_trial |
Involved in clinical trials for new products
|
| gptkbp:community_engagement |
Engages in community support programs
|
| gptkbp:customer_base |
Pharmaceutical and biotech companies
|
| gptkbp:customer_support |
Provides customer support services
|
| gptkbp:economic_activity |
Focus on sustainable business growth
|
| gptkbp:employees |
Approximately 5,000
|
| gptkbp:environmental_impact |
Focus on reducing environmental impact
|
| gptkbp:feedback |
Values customer feedback for improvement
|
| gptkbp:financial_performance |
Publishes annual financial reports
Strong financial performance |
| gptkbp:focus |
Innovative delivery systems
|
| gptkbp:founded |
gptkb:1999
|
| gptkbp:global_presence |
gptkb:battle
|
| gptkbp:governed_by |
Strong corporate governance practices
|
| gptkbp:headquarters |
gptkb:Crystal_Lake,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aptar Pharma
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Continuous innovation in delivery systems
|
| gptkbp:invention |
Numerous patents in drug delivery technology
|
| gptkbp:investment |
Invests in technology and innovation
Active investor relations program |
| gptkbp:market |
Global
Regular product launches Conducts market research for product development Leading provider of drug delivery systems |
| gptkbp:market_segment |
Pharmaceuticals, consumer products, and beauty
|
| gptkbp:marketing_strategy |
Focus on customer needs
|
| gptkbp:partnership |
Various pharmaceutical companies
Engages in technology partnerships |
| gptkbp:partnerships |
Collaborations with research institutions
|
| gptkbp:population_trend |
Monitors market trends
|
| gptkbp:production_location |
Multiple locations worldwide
|
| gptkbp:products |
Drug delivery systems
Strict quality control measures Ongoing product development efforts |
| gptkbp:regulatory_compliance |
Meets global regulatory standards
|
| gptkbp:research_and_development |
gptkb:battle
|
| gptkbp:revenue |
$1.1 billion (2020)
|
| gptkbp:risk_factor |
Implements risk management strategies
|
| gptkbp:sales |
Sales in over 100 countries
|
| gptkbp:services |
Packaging solutions
|
| gptkbp:social_responsibility |
Active in CSR initiatives
|
| gptkbp:strategic_importance |
Engages in strategic planning initiatives
|
| gptkbp:subsidiary |
Aptar Group, Inc.
|
| gptkbp:supply_chain |
Efficient supply chain management practices
Global supply chain management |
| gptkbp:sustainability_initiatives |
gptkb:battle
|
| gptkbp:symbol |
gptkb:ATR
|
| gptkbp:trademark |
Holds several trademarks
|
| gptkbp:training |
Comprehensive training programs
|
| gptkbp:website |
www.aptar.com
|
| gptkbp:bfsParent |
gptkb:Catalent
|
| gptkbp:bfsLayer |
5
|